16 April 2024: The Annual General Meeting of Aker BioMarine ASA was held today
as a digital meeting with online participation.

All proposals on the agenda were adopted, cf. Notice of Annual General Meeting
attached to the stock exchange release dated 20 March 2024.

The complete minutes are attached to this release.


For further information, please contact 
Christopher Robin Vinter, VP IR & Corporate Finance
Mobile: +47 911 60 820 
Email:  Christopher.vinter@akerbiomarine.com  


About Aker BioMarine
Aker BioMarine is a leading biotech innovator and Antarctic krill-harvesting
company developing krill-derived products for consumer health and wellness as
well as animal nutrition. The company has a strong position in its industry and
is the world's leading supplier of krill, the natural, powerful and health
promoting source of nutrients from the pristine waters of Antarctica. Aker
BioMarine is listed on Oslo Stock Exchange (AKBM). More information is available
at www.akerbiomarine.com.

Click here for more information

© Oslo Bors ASA, source Oslo Stock Exchange